Develops robotic technologies for minimally invasive cardiac procedures, focusing on electrophysiology and interventional cardiology.
Stereotaxis, Inc. is a pioneering company specializing in the design, manufacturing, and global distribution of advanced robotic systems, instruments, and information solutions for interventional cardiology and electrophysiology procedures. Headquartered in Saint Louis, Missouri, the company was founded in 1990. Stereotaxis' flagship products include the Genesis RMN and Niobe robotic magnetic navigation (RMN) systems, which revolutionize interventional procedures by providing precise, image-guided navigation of catheters and guidewires through the intricate pathways of the heart's blood vessels and chambers.
In addition to its robotic systems, Stereotaxis offers comprehensive solutions such as Odyssey, an advanced real-time information platform that enhances procedure management, recording, and sharing across healthcare networks. The company's portfolio also features cutting-edge imaging technology, including the Stereotaxis Imaging Model S X-ray system, which integrates high-definition imaging capabilities with robotic precision, essential for optimal outcomes in robotic interventional operating rooms.
Stereotaxis, Inc. supports its innovative technologies with a range of disposables and accessories, including the QuikCAS automated catheter advancement system and various diagnostic and ablation catheters like NAVISTAR RMT THERMOCOOL. Leveraging strategic collaborations, such as its partnership with Osypka AG, Stereotaxis continues to expand its offerings in magnetic ablation catheters, reinforcing its commitment to advancing the standards of care in cardiovascular interventions worldwide.